Evidence-Based Medicine Guidelines
Intermittent versus continuous androgen suppression for prostatic cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intermittent Versus Continuous Androgen Suppression for Prostatic Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455554/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer.
Intermittent versus continuous androgen suppression for prostatic cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/455554/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer. Accessed November 22, 2024.
Intermittent versus continuous androgen suppression for prostatic cancer. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455554/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer
Intermittent Versus Continuous Androgen Suppression for Prostatic Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455554/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intermittent versus continuous androgen suppression for prostatic cancer
ID - 455554
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455554/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
